Abstract:ABSTRACT Chlamydiae are obligate intracellular bacterial pathogens that may cause genital pathology via induction of destructive host immune responses. Human-adapted Chlamydia trachomatis causes inflammatory disease in human hosts but is easily cleared in mice, and mouse-adapted Chlamydia muridarum establishes a productive and pathogenic infection in murine hosts. While numerous anti-chlamydial host resistance factors have been discovered in mice and humans alike, little is known about host factors promoting host fitness independent of host resistance. Here, we show that interferon-inducible immunity-related GTPase M (Irgm) proteins function as such host factors ameliorating infection-associated sequalae in the murine female genital tract, thus characterizing Irgm proteins as mediators of disease tolerance. Specifically, we demonstrate that mice deficient for all three murine Irgm paralogs (pan- Irgm −/− ) are defective for cell-autonomous immunity to C. trachomatis , which correlates with an early and transient increase in bacterial burden and sustained hyperinflammation in vivo . In contrast, upon infection of pan- Irgm −/− mice with C. muridarum , bacterial burden is unaffected, yet genital inflammation and scarring pathology are nonetheless increased, demonstrating that Irgm proteins can promote host fitness without altering bacterial burden. Additionally, pan- Irgm −/− mice display increased granulomatous inflammation in genital Chlamydia infection, implicating Irgm proteins in the regulation of granuloma formation and maintenance. These findings demonstrate that Irgm proteins regulate pathogenic immune responses to Chlamydia infection in vivo , establishing an effective infection model to examine the immunoregulatory functions and mechanisms of Irgm proteins. IMPORTANCE In response to genital Chlamydia infection, the immune system mounts a proinflammatory response to resist the pathogen, yet inflammation must be tightly controlled to avoid collateral damage and scarring to host genital tissue. Variation in the human IRGM gene is associated with susceptibility to autoinflammatory diseases but its role in ameliorating inflammatory diseases caused by infections is poorly defined. Here, we use mice deficient for all three murine Irgm paralogs to demonstrate that Irgm proteins not only provide host resistance to Chlamydia infections but also limit associated inflammation in the female genital tract. In particular, we find that murine Irgm expression prevents granulomatous inflammation, which parallels inflammatory diseases associated with variants in human IRGM. Our findings therefore establish genital Chlamydia infection as a useful model to study the roles for Irgm proteins in both promoting protective immunity and limiting pathogenic inflammation.

The MraY Inhibitor Muraymycin D2 and Its Derivatives Induce Enlarged Cells in Obligate Intracellular Chlamydia and Wolbachia and Break the Persistence Phenotype in Chlamydia

Chlamydia Persistence: A Survival Strategy to Evade Antimicrobial Effects in-vitro and in-vivo

Lipid Requirements for the Enzymatic Activity of MraY Translocases and in Vitro Reconstitution of the Lipid II Synthesis Pathway

An Emerging Role for Cyclic Dinucleotide Phosphodiesterase and Nanornase Activities in Mycoplasma Bovis: Securing Survival in Cell Culture

Inhibitory Activity of Pyrroloisoxazolidine Derivatives Against Chlamydia Trachomatis.

Reprogramming of host glutamine metabolism during Chlamydia trachomatis infection and its key role in peptidoglycan synthesis

Metabolic dormancy in Chlamydia trachomatis treated with different antibiotics

Efficacy of a Novel Affitoxin Targeting Major Outer Membrane Protein Against Chlamydia Trachomatis in Vitro and in Vivo

Efficacy of a novel affitoxin targeting MOMP against Chlamydia trachomatis in vitro and in vivo

Could Dampening Expression of the Neisseria Gonorrhoeae Mtrcde-Encoded Efflux Pump Be a Strategy to Preserve Currently or Resurrect Formerly Used Antibiotics to Treat Gonorrhea?

Tracking Chlamydia – Host interactions and antichlamydial activity in Caenorhabditis elegans

Nafamostat mesylate inhibits chlamydial intracellular growth in cell culture and reduces chlamydial infection in the mouse genital tract

Irgm proteins attenuate inflammatory disease in mouse models of genital Chlamydia infection

Distinct impacts of each anti-anti-sigma factor ortholog of the chlamydial Rsb partner switching mechanism on development in Chlamydia trachomatis

New Horizons in Mycoplasma genitalium Treatment

The Chlamydia effector CpoS modulates the inclusion microenvironment and restricts the interferon response by acting on Rab35

Acylpyrazoline-Based Third-Generation Selective Antichlamydial Compounds with Enhanced Potency

Silencing or permanent activation: host-cell responses in models of persistent Chlamydia pneumoniae infection

MtrAB two-component system is crucial for the intrinsic resistance and virulence of

Aberrant Bodies: An Alternative Metabolic Homeostasis Allowing Survivability?

Pathogenic Chlamydia Lack a Classical Sacculus but Synthesize a Narrow, Mid-cell Peptidoglycan Ring, Regulated by MreB, for Cell Division